102 related articles for article (PubMed ID: 9424348)
1. [Sirdalud in the practice of the pediatric neurologist].
Shumilina AP; Guzeva VI; Skoromets AA
Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(10):45-6. PubMed ID: 9424348
[No Abstract] [Full Text] [Related]
2. [The use of sirdalud in cerebral palsy in children].
Brin IL; Kurenkov AL; Gotlib VIa
Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(10):30-3. PubMed ID: 10536809
[TBL] [Abstract][Full Text] [Related]
3. [The use of sirdalud in painful muscle tonic syndromes].
Damulin IV
Ter Arkh; 1997; 69(10):68-72. PubMed ID: 9471796
[TBL] [Abstract][Full Text] [Related]
4. [The use of sirdalud in the treatment of spasticity in infantile cerebral palsy].
Maksimov OG; Secheĭko MV; Andriĭchuk EL
Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(3):22-3. PubMed ID: 10205837
[No Abstract] [Full Text] [Related]
5. [Treatment of spasticity].
Autti-Rämö I
Duodecim; 1999; 115(8):877-85. PubMed ID: 11859520
[No Abstract] [Full Text] [Related]
6. Continuous intrathecal baclofen therapy in children with cerebral palsy - when does improvement emerge?
Ramstad K; Jahnsen R; Lofterod B; Skjeldal OH
Acta Paediatr; 2010 Nov; 99(11):1661-5. PubMed ID: 19912148
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of botulinum toxin type A with oral anti-spasticity medications in the management of focal spasticity.
Dai A
J Rehabil Med; 2007 Mar; 39(2):189; author reply 189. PubMed ID: 17351705
[No Abstract] [Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of tizanidine.
Roberts RC; Part NJ; Pokorny R; Muir C; Leslie GC; Emre M
Neurology; 1994 Nov; 44(11 Suppl 9):S29-31. PubMed ID: 7970008
[TBL] [Abstract][Full Text] [Related]
9. New approaches to managing spasticity in children with cerebral palsy.
Im D; McDonald CM
West J Med; 1997 Apr; 166(4):271. PubMed ID: 9168686
[No Abstract] [Full Text] [Related]
10. Dantrolene: new indication. Cerebral palsy in children: uncertain clinical benefit.
Prescrire Int; 2008 Dec; 17(98):237. PubMed ID: 19422149
[TBL] [Abstract][Full Text] [Related]
11. [Intrathecal baclofen for treatment of spasticity in patient with cerebral palsy--a preliminary report].
Jóźwiak M; Idzior M; Huber J; Szulc A; Grottel K
Chir Narzadow Ruchu Ortop Pol; 2003; 68(4):253-9. PubMed ID: 14702678
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
Dai AI; Wasay M; Awan S
J Child Neurol; 2008 Dec; 23(12):1464-6. PubMed ID: 19073853
[TBL] [Abstract][Full Text] [Related]
13. Analysis of gait and isokinetic movements for evaluation of antispastic drugs or physical therapies.
Knutsson E
Adv Neurol; 1983; 39():1013-34. PubMed ID: 6229155
[No Abstract] [Full Text] [Related]
14. Epilepsy and intrathecal baclofen therapy in children with cerebral palsy.
Buonaguro V; Scelsa B; Curci D; Monforte S; Iuorno T; Motta F
Pediatr Neurol; 2005 Aug; 33(2):110-3. PubMed ID: 16087055
[TBL] [Abstract][Full Text] [Related]
15. Biological fate of sirdalud in animals and man.
Koch P; Hirst DR; von Wartburg BR
Xenobiotica; 1989 Nov; 19(11):1255-65. PubMed ID: 2618078
[TBL] [Abstract][Full Text] [Related]
16. Treatment of children with cerebral palsy.
Dai AI
J Pediatr Orthop B; 2007 Jul; 16(4):303. PubMed ID: 17527111
[No Abstract] [Full Text] [Related]
17. An overview of drug therapies used in the treatment of dystonia and spasticity in children.
Tickner N; Apps JR; Keady S; Sutcliffe AG
Arch Dis Child Educ Pract Ed; 2012 Dec; 97(6):230-5. PubMed ID: 22896738
[No Abstract] [Full Text] [Related]
18. [Pathogenetic therapy of spasticity].
Kasatkin DS
Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(3):80-5. PubMed ID: 18697257
[No Abstract] [Full Text] [Related]
19. Improvements in children with cerebral palsy following intrathecal baclofen: use of the Rehabilitation Institute of Chicago Care and Comfort Caregiver Questionnaire (RIC CareQ).
Baker KW; Tann B; Mutlu A; Gaebler-Spira D
J Child Neurol; 2014 Mar; 29(3):312-7. PubMed ID: 23420651
[TBL] [Abstract][Full Text] [Related]
20. [Disorders of muscle tonus and their treatment with sirdalud in patients in the early recovery period of ischemic stroke].
Gekht AB; Burd GS; Selikhova MV; Iaish F; Beliakov VV
Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(10):22-9. PubMed ID: 9819884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
